What it sells
Raywatt develops cardiovascular OCT (optical coherence tomography) medical devices to improve the lives of cardiovascular patients worldwide.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-11-11 | — | KRW 13B | — | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-11-12.